Normal view MARC view ISBD view

Safe and effective use of rivaroxaban for treatment of cancer-associated venous thromboembolic disease: a prospective cohort study.

Safe and effective use of rivaroxaban for treatment of cancer-associated venous thromboembolic disease: a prospective cohort study. - 2017

English

ISSN: 0929-5305

Subjects--Topical Terms:
*Neoplasms/co [Complications]
*Rivaroxaban/tu [Therapeutic Use]
*Venous Thromboembolism/dt [Drug Therapy]
Anticoagulants/tu [Therapeutic Use]
Cohort Studies
Female
Hemorrhage/ci [Chemically Induced]
Humans
Male
Middle Aged
Neoplasms/dt [Drug Therapy]
Prospective Studies
Recurrence
Rivaroxaban/st [Standards]
Treatment Outcome
Venous Thromboembolism/et [Etiology]

Subjects--Geographic Terms:
MedStar Washington Hospital Center

Index Terms--Occupation:
Hematology/Oncology

Index Terms--Function:
Journal Article
Validation Studies

Print
Add to your cart (remove)
Save record
BIBTEX Dublin Core MARCXML MARC (non-Unicode/MARC-8) MARC (Unicode/UTF-8) MARC (Unicode/UTF-8, Standard) MODS (XML) RIS ISBD
More searches

Search for this title in:
Other Libraries (WorldCat) Other Databases (Google Scholar) Online Stores (Bookfinder.com) Open Library (openlibrary.org)